China needs good Covid 19 booster vaccine like Covovax, but they haven't given a positive response: Adar Poonawalla

ANI
25 Jan 2023, 21:26 GMT+10

New Delhi [India], January 25 (ANI): China needs a good Covid 19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.

Talking to ANI, Poonawalla said, "Covovax is an excellent vaccine against Omicron. We have got a lot of data and global trials for it. It's approved in the US and Europe which no other Indian COVID vaccine has. Let's see how it goes.""We haven't received positive response from China. They need a good booster like our Covovax vaccine which is approved by DCGI and will soon be available on the COVID app," he added.

As per sources, NTAGI is likely to soon meet regarding the inclusion of Covid vaccine Covovax on the CoWIN portal as heterologous booster dose for adults to boost uptake of booster doses.

The Serum Institute of India has also written a letter to the Union Health Ministry seeking inclusion of its Covid vaccine Covovax on the CoWIN portal.

On January 16, Drugs Controller General of India (DCGI) has approved market authorisation for Serum Institute of India (SII) COVID jab Covovax, as heterologous booster dose.

Notably, the government panel of Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as heterologous booster dose for those who have already taken two doses of Covishield or Covaxin.

Adar further said that SII is also working on the Malaria vaccine for Africa. The vaccine for dengue is underway, which is expected in two years. (ANI)

Watch latest videos

News RELEASES

Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to China National News.

More Information

null in null

Business

Section

Nasdaq Composite surges more than 12% as Trump agrees he misfired

Extraordinary gains on Wall Street as Trump backflips on tariffs

NEW YORK, New York - U.S. stocks roared back to life on Wednesday after U.S. President Donald Trump back flipped on his recently announced...

Texas probes WK Kellogg over ‘healthy’ label claims

Texas opens probe into WK Kellogg over health claims

AUSTIN, Texas: Attorney General Ken Paxton announced over the weekend that the state has launched an investigation into a company,...

Jaguar Land Rover halts US exports amid new tariffs

UK's Jaguar Land Rover to pause shipments to US over tariffsar Land Rover to pause shipments to US over tariffs

LONDON, U.K.: Jaguar Land Rover has become one of the first major carmakers to pause exports to the United States in response to the...

Medicare backs off Biden plan for weight-loss drug coverage

Trump administration drops Medicare weight-loss drug coverage

WASHINGTON, D.C.: The Centers for Medicare & Medicaid Services (CMS) says it will not go ahead with a plan from the Biden administration...

U.S. stock markets slide again as tariffs on China rise to 104%

U.S. stocks tumble amid global surge, Dow Jones dives 320 points

NEW YORK, New York - U.S. stocks tumbled again on Tuesday, igniting fear of the fallout from U.S. President's Donald Trump's trade...

Nissan eyes manufacturing shift to dodge US Tariffs

Nissan considers transferring some domestic production to US

TOKYO, Japan: Nissan may soon make a strategic shift in its manufacturing operations, according to a new report from Japan's Nikkei...

Asia Pacific

Section